Activity of novel cytotoxic agents in lung cancer: epothilones and topoisomerase I inhibitors.

Clinical lung cancer

Volumn 7 Suppl 1, Issue , 2005, Pages

  Wakelee, Heather A ^a   Sikic, Branimir I ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA TOPOISOMERASE; ENZYME INHIBITOR; EPOTHILONE DERIVATIVE;

CLINICAL TRIAL; DRUG ANTAGONISM; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; PATHOPHYSIOLOGY; PROGNOSIS; REVIEW; SMALL CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; CLINICAL TRIALS; DNA TOPOISOMERASES, TYPE I; ENZYME INHIBITORS; EPOTHILONES; HUMANS; LUNG NEOPLASMS; PROGNOSIS;

MLCS; MLOWN;

EID: 33644626203     PISSN: 15257304     EISSN: None     Source Type: Journal    
DOI: 10.3816/clc.2005.s.002     Document Type: Review

References (61)